Cytochrome P450 2C19 polymorphism and clopidogrel after MI

被引:4
|
作者
Bhattacharyya, Sanjeev [1 ]
Rakhit, Roby [1 ]
机构
[1] Royal Free Hosp, Dept Cardiol, London NW3 2QG, England
来源
LANCET | 2009年 / 373卷 / 9670期
关键词
OUTCOMES;
D O I
10.1016/S0140-6736(09)60679-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1171 / 1171
页数:1
相关论文
共 50 条
  • [41] Effect of cytochrome P450 2C19 (CYP2C19) gene polymorphism and clopidogrel reactivity on long term prognosis of patients with coronary heart disease after PCI
    Hu, Cheng-Yan
    Wang, Yan-Ling
    Fan, Zhen-Xing
    Sun, Xi-Peng
    Wang, Shuai
    Liu, Zhi
    JOURNAL OF GERIATRIC CARDIOLOGY, 2024, 21 (01) : 90 - 103
  • [42] CYTOCHROME P450 2C19 POLYMORPHISM IN ACUTE ISCHEMIC STROKE IN NORTH-WEST OF IRAN
    Faroudi, M.
    Hokmabadi, E. Sadeghi
    Mehdizadehfar, E.
    Sadeghpour, Y.
    Sakhinia, E.
    Rahnemayan, S.
    Taheraghdam, A.
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (02) : 395 - 395
  • [43] Effect of cytochrome P450 2C19(CYP2C19) gene polymorphism and clopidogrel reactivity on long term prognosis of patients with coronary heart disease after PCI
    Cheng-Yan HU
    Yan-Ling WANG
    Zhen-Xing FAN
    Xi-Peng SUN
    Shuai WANG
    Zhi LIU
    Journal of Geriatric Cardiology, 2024, 21 (01) : 90 - 103
  • [44] Cytochrome P450 2C19 Polymorphism and Antiplatelet Therapy. Who Should Really be Genotyped?
    Kassimis, George
    Stavrou, Eleana F.
    Alexopoulos, Dimitrios
    Athanassiadou, Aglaia
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (13) : 2489 - 2495
  • [45] Catalytic enhancements in cytochrome P450 2C19 by cytochrome b5
    Gyu-Hyeong Lee
    Vitchan Kim
    Sung-Gyu Lee
    Eunseo Jeong
    Changmin Kim
    Yoo-Bin Lee
    Donghak Kim
    Toxicological Research, 2024, 40 : 215 - 222
  • [46] Development of PNA-Array Platforms for Detection of Genetic Polymorphism of Cytochrome P450 2C19
    Hong, Daewha
    Park, Hyung Ju
    Chi, Young Shik
    Lee, Young
    Lee, Juno
    Kang, Hyo Jin
    Park, Dae Keun
    Chung, Sang J.
    Yun, Wan Soo
    Choi, Insung S.
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2011, 32 (08) : 2895 - 2896
  • [47] A rapid and simple detection of genetic defects responsible for the phenotypic polymorphism of cytochrome P450 2C19
    Itoh, K
    Inoue, K
    Yanagiwara, S
    Kyoya, H
    Suzuki, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1999, 22 (01) : 77 - 79
  • [48] Catalytic enhancements in cytochrome P450 2C19 by cytochrome b5
    Lee, Gyu-Hyeong
    Kim, Vitchan
    Lee, Sung-Gyu
    Jeong, Eunseo
    Kim, Changmin
    Lee, Yoo-Bin
    Kim, Donghak
    TOXICOLOGICAL RESEARCH, 2024, 40 (02) : 215 - 222
  • [49] Cytochrome P450 2C19*2 polymorphism diminishes peri-interventional antiplatelet effect of clopidogrel in patients undergoing percutaneous coronary intervention
    Trenk, D.
    Hochholzer, W.
    Fromm, M. F.
    Chialda, L.
    Pahl, A.
    Neumann, F. -J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 14 - 14
  • [50] Relationship between Cytochrome P450 2C19*2 Polymorphism and Stent Thrombosis following Percutaneous Coronary Intervention in Chinese Patients Receiving Clopidogrel
    Luo, Y.
    Zhao, Y-T
    Verdo, A.
    Qi, W-G
    Zhang, D-F
    Hu, B.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2011, 39 (05) : 2012 - 2019